- Barclays cut AT&T Inc. price target from $22 to $20. AT&T shares fell 0.6% to $18.81 in pre-market trading.
- UBS cut the price target on The Scotts Miracle-Gro Company from $125 to $92. Scotts Miracle-Gro shares fell 0.9% to $86.45 in pre-market trading.
- Keybanc reduced Atlassian Corporation Plc price target from $338 to $278. Atlassian shares fell 0.2% to $213.73 in pre-market trading.
- SVB Leerink raised 1Life Healthcare, Inc. price target from $9 to $18. 1Life Healthcare shares fell 0.4% to $17.18 in pre-market trading.
- Raymond James reduced D.R. Horton, Inc. price target from $120 to $103. D.R. Horton shares fell 0.2% to $75.70 in pre-market trading.
Several analysts made changes to their price targets on Snap following the release of results.
- Citigroup lowered price target on the stock from $29 to $16.
- RBC Capital lowered Snap price target from $17 to $10.
- Barclays cut the price target on the stock from $20 to $15.
- Rosenblatt lowered the price target from $23 to $14.
- JMP Securities lowered Snap price target from $42 to $24.
- Benchmark cut the price target on the stock from $20 to $15.
- Credit Suisse lowered Snap price target from $45 to $35.
- Evercore ISI Group cut the price target on the stock from $26 to $14.
- Piper Sandler lowered Snap price target from $18 to $11.
- Stifel cut the price target on the stock from $20 to $14.
- Goldman Sachs lowered Snap price target from $25 to $12.
- Atlantic Equities cut the price target on the stock from $18 to $13.
Comments